Skip to content

Atellica IM CsA 10995548Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · Cyclosporine (CsA) Atellica IM - RGT 50T · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00630414598727), received between Jan 20, 2026 and Jan 20, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Low Test Results” (2 reports).

1 other recall cover devices cleared under the same FDA submission (K071455); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 2 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Low Test Results2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 20, 2026Low Test Results

    THE CUSTOMER COMPLAINED OF LOW ATELLICA IM CYCLOSPORINE (CSA) LOT 055 PATIENT RESULTS. A DISCORDANT RESULT WAS IDENTIFIED WHERE A PATIENT SAMPLE TESTED ON (B)(6) 2025 WITH ATELLICA IM CSA RESULTED LOWER THAN A RESULT FROM AN ALTERNATE METHOD OBTAINED AT A DIFFERENT LAB. THERE ARE NO REPORTS OF PATIENT OR USER INTERVENTION OR ADVERSE HEALTH CONSEQUENCES IN ASSOCIATION WITH THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24116830 ↗
  • MalfunctionJan 20, 2026Low Test Results

    THE CUSTOMER REPORTED DISCORDANT (LOW) ATELLICA IM CYCLOSPORINE (CSA) LOT 055 PATIENT RESULTS. THE CUSTOMER PROVIDED DATA FOR 2 PATIENT SAMPLES TESTED ON (B)(6) 2026 WHERE THE INITIAL ATELLICA IM CSA WERE LOWER THAN RESULTS FROM AN ALTERNATE METHOD OBTAINED AT A DIFFERENT LAB. THERE ARE NO REPORTS OF PATIENT OR USER INTERVENTION OR ADVERSE HEALTH CONSEQUENCES IN ASSOCIATION WITH THIS EVENT

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24114920 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K071455. One submission often covers many models, so check the product and lot details in each record.

  • Z-1687-2018 · Jan 2, 2018 · Terminated
    ADVIA Centaur Cyclosporine

Other CYCLOSPORINE devices

All CYCLOSPORINE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page